Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
787
-
Total 13F shares, excl. options
-
320M
-
Shares change
-
-8.74M
-
Total reported value, excl. options
-
$12.7B
-
Value change
-
-$342M
-
Put/Call ratio
-
0.6
-
Number of buys
-
351
-
Number of sells
-
-319
-
Price
-
$39.82
Significant Holders of GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) as of Q2 2021
877 filings reported holding GSK - GLAXOSMITHKLINE PLC - SPONSORED ADR as of Q2 2021.
GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) has 787 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 320M shares
.
Largest 10 shareholders include Dodge & Cox (88.2M shares), Capital International Investors (22.7M shares), Fisher Asset Management, LLC (17.5M shares), FMR LLC (17M shares), PRICE T ROWE ASSOCIATES INC /MD/ (14.7M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (9.54M shares), STATE STREET CORP (9.16M shares), Black Creek Investment Management Inc. (9.09M shares), RENAISSANCE TECHNOLOGIES LLC (9.06M shares), and UBS Group AG (7.44M shares).
This table shows the top 787 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.